Novotech

Novotech, established in 1997, is a prominent global full-service clinical Contract Research Organization (CRO). Operating within the Business Services sector, the company specializes in accelerating the development of advanced and novel therapeutics. With a significant international footprint, Novotech partners extensively with biotech companies across various phases of drug development. Its core mission revolves around providing comprehensive clinical research services to facilitate the journey from early-stage research to market approval.

The organization employs between 1,000 and 5,000 professionals and maintains operations across 49 locations worldwide, underscoring its extensive global reach. Novotech's expertise lies in navigating complex clinical trials and regulatory landscapes, particularly within the Asia Pacific region, including key markets like Australia, New Zealand, Singapore, China, and India. This extensive network allows for efficient project delivery and access to diverse patient populations. For insights into the people driving these operations, you can Meet Novotech's team.

Novotech's service suite encompasses all phases of clinical development, offering specialized contract research and expert consulting services. They focus on partnering with biotech firms to advance novel therapies, leveraging their deep understanding of regional markets and regulatory requirements. The company's commitment to best-in-class project delivery ensures that clients receive experienced guidance throughout the therapeutic development lifecycle, from initial concept to regulatory clearance.